Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
about
Efficacy and Safety of Dorocontin(®) versus Sustac(®) in the Treatment of Stable Angina Pectoris: A Randomized, Double-Blind Comparative Trial.What do prescribers think of biosimilars?Investigation of the efficacy of generic and brand-name tiotropium bromide in the management of chronic obstructive pulmonary disease: A randomized comparative trial.
P2860
Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Generics and cost-effective pr ...... te in therapeutic equivalence?
@ast
Generics and cost-effective pr ...... te in therapeutic equivalence?
@en
Generics and cost-effective pr ...... te in therapeutic equivalence?
@nl
type
label
Generics and cost-effective pr ...... te in therapeutic equivalence?
@ast
Generics and cost-effective pr ...... te in therapeutic equivalence?
@en
Generics and cost-effective pr ...... te in therapeutic equivalence?
@nl
prefLabel
Generics and cost-effective pr ...... te in therapeutic equivalence?
@ast
Generics and cost-effective pr ...... te in therapeutic equivalence?
@en
Generics and cost-effective pr ...... te in therapeutic equivalence?
@nl
P2860
P356
P1433
P1476
Generics and cost-effective pr ...... te in therapeutic equivalence?
@en
P2093
P2860
P304
P356
10.1179/ACB.2009.067
P577
2009-09-01T00:00:00Z